Lead- and device-related complications in the Antiarrhythmics Versus Implantable Defibrillators Trial
- 1 January 2001
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 141 (1) , 92-98
- https://doi.org/10.1067/mhj.2001.111261
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Complications of Third‐Generation Implantable Cardioverter Defibrillator TherapyPacing and Clinical Electrophysiology, 1999
- ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive SummaryCirculation, 1998
- Long-term Follow-up of Cardioverter-Defibrillator Implanted Under Conscious Sedation in Prepectoral Subfascial PositionCirculation, 1997
- Postoperative lead-related complications in patients with nonthoracotomy defibrillation lead systemsJournal of the American College of Cardiology, 1995
- Results of the International Study of the Implantable Pacemaker Cardioverter-DefibrillatorCirculation, 1995
- Limitations and Late Complications of Third-Generation Automatic Cardioverter-DefibrillatorsCirculation, 1995
- Three-year outcome of a nonthoracotomy approach to cardioverter-defibrillator implantation in 189 consecutive patientsThe American Journal of Cardiology, 1994
- Implantation by electrophysiologists of 100 consecutive cardioverter defibrillators with nonthoracotomy lead systems.Circulation, 1994
- Electrophysiological laboratory, electrophysiologist-implanted, nonthoracotomy-implantable cardioverter/defibrillators.Circulation, 1994
- Sensing/pacing lead complications with a newer generation implantable cardioverter-defibrillator: Worldwide experience from the guardian ATP 4210 clinical trialJournal of the American College of Cardiology, 1994